ATC-38607-29309
1 vaccination
6 coded responses
6 check-ins
6 free-text entries
5 call cases
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 330 / FL
- Registered
- 2021-01-07
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-28
Dose 1 — Moderna
-
2021-01-07
Registered in v-safe
-
2021-01-07
Survey response — day 7, dose 1MedDRA: Auditory nerve disorder, Sudden hearing loss, Vestibular neuronitis — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Be unable to work, Be unable to do your normal daily activitiesFree text: Sudden hearing loss due to inflammation of auditory nerve in right ear on January 6thMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-07
Report sent to call center — day 7, dose 1Be unable to work · Be unable to do your normal daily activitiesno matching call case
-
2021-01-19
Survey response — day 21, dose 1MedDRA: Deafness neurosensory, Hyperacusis, Tinnitus — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Tinnitus, hyperacusis post sudden sensorineural hearing lossMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-19
Report sent to call center — day 21, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-01-25
Survey response — day 28, dose 1MedDRA: Deafness unilateral, Tinnitus — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Recovering from sudden hearing loss of 30 decibels across frequencies in right ear, continued tinnitusMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-25
Report sent to call center — day 28, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-02-01
Survey response — day 35, dose 1MedDRA: Deafness neurosensory, Tinnitus — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Recovering from sudden sensorineural hearing loss. Continued tinnitus.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-01
Report sent to call center — day 35, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-02-10
Survey response — day 42, dose 1MedDRA: Deafness neurosensory, Tinnitus — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Recovering from sensorineural hearing loss. Continued tinnitus.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-10
Report sent to call center — day 42, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-03-29
Survey response — 3 months, dose 1MedDRA: Deafness neurosensory, Tinnitus — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Tinnitus related to sensorineural hearing lossMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-29
Report sent to call center — 3 months, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-05-02
-
2021-05-04
Call successfulReported to VAERS voluntarily prior to GDIT contact
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-28 | Moderna |
Call center
5 call center cases
5 successful
VAERS report filed, before or during a call: 5
1 check-in flagged for a call with no call center case on record
Free text
Release 1 — day 7, dose 1
Systemic reaction (other): Sudden hearing loss due to inflammation of auditory nerve in right ear on January 6th
Release 2 — day 21, dose 1
Symptoms: Tinnitus, hyperacusis post sudden sensorineural hearing loss
Release 2 — day 28, dose 1
Symptoms: Recovering from sudden hearing loss of 30 decibels across frequencies in right ear, continued tinnitus
Release 3 — day 35, dose 1
Symptoms: Recovering from sudden sensorineural hearing loss. Continued tinnitus.
Release 4 — day 42, dose 1
Symptoms: Recovering from sensorineural hearing loss. Continued tinnitus.
Release 6 — 3 months, dose 1
Symptoms: Tinnitus related to sensorineural hearing loss
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Deafness neurosensory | ✓ | ✓ | ✓ |
| SD | Deafness unilateral | ✓ | ✓ | ✓ |
| SD | Hyperacusis | ✓ | ✓ | ✓ |
| SD | Tinnitus | ✓ | ✓ | ✓ |
| SRO | Auditory nerve disorder | ○ | ✓ | ○ |
| SRO | Sudden hearing loss | ✓ | ✓ | ✓ |
| SRO | Vestibular neuronitis | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release